Light Therapy Market (2026 - 2033)

Light Therapy Market Summary

The global light therapy market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.4 billion in 2026 to USD 2.4 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. North America held the largest global share of over 35.0% in 2025.

The light therapy industry’s growth is driven by the increasing prevalence of skin disorders such as acne, psoriasis, and eczema, which are commonly treated with light-based therapies. The rising incidence of sleep disorders, depression, and seasonal affective disorder (SAD) is also contributing to market growth. The growing adoption of non-invasive treatments and the rising prevalence of skin diseases are driving the market. Moreover, market players are engaged in various strategic initiatives, such as product launches, that are fostering the industry’s growth.

The market is witnessing strong growth driven by rising consumer awareness of circadian rhythm management, seasonal affective disorder (SAD), and the benefits of photobiomodulation for pain management and wound healing. The growing preference for at-home treatment devices, driven by advancements in portable and wearable light therapy solutions, is further accelerating adoption across both clinical and personal care segments. Technological advancements such as LED-based devices, smart connectivity features, and wavelength-specific customization are improving treatment efficacy and user convenience. Furthermore, expanding applications in dermatology, particularly for acne, psoriasis, and vitiligo, are broadening the clinical use base of light therapy systems.

The growing integration of light therapy in wellness and aesthetic clinics, coupled with rising healthcare expenditure and favorable reimbursement frameworks in select developed markets, is also supporting market expansion. However, factors such as high device costs in advanced systems and limited awareness in emerging economies may slightly restrain broader adoption in the near term.

Market Dynamics

The rising global burden of mental health disorders, skin diseases, and sleep-related conditions primarily drives the light therapy market. Increasing cases of depression, anxiety, and circadian rhythm disruptions are boosting demand for non-invasive and drug-free treatment options such as LED and UV light therapy. Growing awareness of home-based wellness solutions and the preference for safer, pharmaceutical-free therapies are further supporting adoption across both clinical and consumer segments.

Analyst Perspective

The light therapy market is growing at the intersection of medical treatment and consumer wellness, driven by rising demand for non-invasive, drug-free solutions. It is used for conditions such as acne, skin disorders, sleep problems, and seasonal mood issues, and is also seeing rising adoption in home-based skincare and wellness devices. The market is gradually shifting from simple devices to connected systems that offer guided usage and personalized treatment plans. Overall, growth is supported by higher health awareness and the preference for safe, easy-to-use therapies.

Product Insights

The handheld device segment led the light therapy market, accounting for the largest revenue share of approximately 30.0% in 2025. This can be attributed to the product’s wide range of features, including portability, efficient technology, and user-friendliness. They are used for skin treatment and employ technologies such as ultrasonic waves and microcurrents to improve the appearance of the skin. For instance, in September 2025, Biophotas launched the Celluma POD Series 2, expanding its portfolio of portable light therapy solutions. The battery-powered handheld LED device received FDA clearance for four treatment modes: acne, pain management, aging skin, and body contouring.

The light visor segment is expected to grow at the fastest CAGR over the forecast period. The segment growth is driven by the increase in aircraft travelers, which has led to various conditions, including insomnia, eye fatigue, and jet lag. This is due to changes in time zones and sleep patterns. It is portable and user-friendly, and can be worn on the head. It regulates melatonin levels and improves the body's circadian rhythms.

Application Insights

The sleeping disorder segment led the light therapy industry, accounting for the largest revenue share of approximately 25.0% in 2025. There are various conditions related to sleep disorders, such as insomnia, hypersomnia, and sleep-disordered breathing. These conditions are often linked to unhealthy lifestyle habits, including smoking, excessive alcohol consumption, irregular sleep schedules, and increased screen time before bedtime. Light therapy has emerged as an effective non-pharmacological treatment option for sleep disorders. Its ability to regulate the body's internal clock, improve sleep quality, and reduce reliance on medications has increased its adoption among both healthcare providers and consumers. Supporting this trend, in October 2025, Helight introduced its red-light sleep therapy device through Ulta Beauty stores. The device is designed to improve sleep quality and support circadian rhythm regulation through scientifically calibrated red-light exposure, highlighting the growing consumer acceptance of light-based therapies for managing insomnia and other sleep-related disorders.

The SAD/winter blues segment is expected to grow at the fastest CAGR over the forecast period. This growth is attributed to the increasing screen time and unhealthy lifestyle habits, including limited physical activity, poor dietary patterns, and spending extended periods indoors during the winter months.

Light Type Insights

The blue light segment led the light therapy market, accounting for more than 40.0% of revenue in 2025, and is expected to grow at the fastest CAGR over the forecast period. Blue light therapy is used to treat various conditions such as acne, skin disorders, depression, and seasonal affective disorder. The treatment session, depending on the condition and treatment area, varies from 15 minutes to 90 minutes.

According to the AAD association, 9,500 people in the U.S. are diagnosed with skin cancer daily, and approximately 1 million people in the U.S. are suffering from melanoma. Studies suggest that blue light therapy is effective in treating melanoma, which is expected to drive the market demand for blue light therapy devices. Growing awareness regarding aesthetic appearance, especially among younger consumers, is further supporting market expansion. According to a study published in the Journal of Photochemistry and Photobiology B: Biology in December 2025, a novel 450-nm blue laser-mediated photodynamic therapy demonstrated strong antibacterial activity against Cutibacterium acnes, the primary bacterium associated with acne vulgaris. The researchers found that the therapy generated high levels of reactive oxygen species (ROS), leading to bacterial destruction and reduced acne-related inflammation.

End Use Insights

The home healthcare segment led the light therapy industry, accounting for the largest revenue share of over 55.0% in 2025. Increasing consumer awareness of the benefits of light-based treatments and technological advancements, such as remote patient monitoring, is driving market growth. In addition, the increasing prevalence of acne, psoriasis, eczema, skin rejuvenation procedures, and other dermatological conditions is driving patients to dermatology clinics. The adoption of advanced light therapy systems, including LED- and laser-based devices, enables clinics to offer effective, non-invasive treatment options with minimal recovery.

Dermatology clinics specialize in treating various skin conditions, such as acne, eczema, psoriasis, and vitiligo. According to WHO estimates, skin diseases affect almost 900 million people, which is expected to drive demand for dermatology clinics. Moreover, the increasing adoption of non-invasive treatments and technological advancements, such as laser technology, is expected to drive market growth over the forecast period.

Regional Insights

North America dominated the global light therapy market, accounting for the largest revenue share of over 35.0% in 2025, owing to rising cases of SAD/Winter blues and psoriasis. Light therapy involves exposing the skin to ultraviolet light from artificial sources under medical supervision. UVB and UVA light, or a combination of both, are used to reduce inflammation, slow down skin cell growth, and improve symptoms. According to estimates by the Canadian Dermatology Association, approximately 1 million people have psoriasis, which is increasing the market for these devices. Furthermore, product innovations are contributing to market expansion. In January 2025, Nanoleaf launched its LED Light Therapy Face Mask. The device uses red and blue LED light therapy to support acne treatment, highlighting the growing adoption of advanced at-home light therapy solutions in the U.S. market.

Europe Light Therapy Market Trends

The Europe light therapy industry is expected to grow significantly during the forecast period. This is attributed to the prevalence of various skin conditions such as psoriasis, acne, and vitiligo in the region. Moreover, increasing cases of SAD and winter blues in the region are further driving the demand. The market is driven by increasing awareness about the benefits of light therapy in treating seasonal affective disorder (SAD) and other mood disorders. In addition, the rising adoption of light therapy devices in the homecare segment and the growing number of people suffering from SAD and other mood disorders are also driving the market growth.

Asia Pacific Light Therapy Market Trends

The Asia Pacific light therapy industry is experiencing significant growth, driven by rising awareness of its benefits and increased investments in telemedicine. In addition, the increasing adoption of light therapy devices in hospitals, clinics, and the home care segment is also driving growth. The market is expected to continue growing over the coming years, driven by the rising prevalence of sleep disorders and the increasing adoption of light therapy devices for the treatment of skin conditions such as acne, psoriasis, and eczema.

Key Light Therapy Company Insights

The key players are implementing strategies such as new product launches, mergers, collaborations, partnerships, and acquisitions to improve their market position. Several players are attempting to implement demand-friendly strategic plans. Zerigo Health has a mobile application that automatically calculates and prescribes dosages based on the patient’s condition. In addition, the company has a GPS tracker that shows progress and provides 1-to-1 consultation.

• In July 2025, BioPhotas, Inc., announced the launch of the Celluma NOVA, a first-of-its-kind 5-mode, battery-powered, FDA-cleared LED light therapy device. The innovation enhances portability and clinical versatility, addressing skin aging, acne, pain management, hair restoration, and body contouring within a single compact, professional-grade platform for at-home and clinical applications.

• In March 2025, Biophotas Inc. introduced its latest product, the Celluma PRO Plus, strengthening its portfolio of advanced LED light therapy solutions. The device addresses acne treatment, pain management, and wrinkles.

Key Light Therapy Companies

The following key companies have been profiled for this study of the light therapy market.

• Koninklijke Philips N.V.

• Beurer GmbH

• Biophotas

• Northern Light Technologies

• Lumie

• Verilux, Inc.

• The Daylight Company Ltd.

• Zerigo Health

• NATUREBRIGHT

• Zepter IT

Light Therapy Market Report Scope

Global Light Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global light therapy market report based on product, application, light type, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Light Box

  • Floor and Desk Lamps

  • Handheld Devices for Skin Treatment

  • Light Visor

  • Dawn Simulator

  • Light Therapy Lamps

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Psoriasis

  • Vitiligo

  • Eczema

  • Acne Vulgaris

  • SAD/Winter Blues

  • Sleeping Disorders

• Light Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Blue Light

  • Red Light

  • White Light

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Dermatology Clinics

  • Home Healthcare

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait